SUNREST — Sunrest Lifescience Cashflow Statement
0.000.00%
- IN₹270.35m
- IN₹298.95m
- IN₹246.42m
- 25
- 47
- 43
- 29
Annual cashflow statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Net Income/Starting Line | 2.24 | 10.5 | 27.4 |
Depreciation | |||
Non-Cash Items | 0.076 | -0.116 | 0.591 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -1.21 | -15.5 | -17.8 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | 1.53 | -4.49 | 11.5 |
Capital Expenditures | -1.62 | -4.67 | -0.142 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | — | 1.1 | -0.165 |
Sale of Fixed Assets | |||
Purchase of Investments | |||
Cash from Investing Activities | -1.62 | -3.56 | -0.307 |
Financing Cash Flow Items | -0.075 | -0.108 | -0.591 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 0.381 | 9.12 | -11.5 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.296 | 1.07 | -0.301 |